| JEMLYNK DAIICHI SANKYO COMPANY LIMITED
2248785 25 Jan 2023 | on 25 Jun 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of cardiovascular diseases. | | | JEMLYNK DAIICHI SANKYO COMPANY LIMITED
2183651 04 Mar 2022 | on 22 Dec 2023 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of cardiovascular diseases. | | | JEMLANON N.V. ORGANON
1303242 29 May 2006 | on 01 Jun 2007 | Class 005 Class 005 Pharmaceutical Products Class 010 Class 010 Medical Instrument Products Medicines and pharmaceutical preparations for human use; medical apparatus. | | | JEMLANON MSD OSS B.V.
1300670 05 May 2006 | on 23 May 2012 | Class 005 Class 005 Pharmaceutical Products Class 010 Class 010 Medical Instrument Products Medicines and pharmaceutical preparations for human use, namely, pharmaceutical preparations for the treatment of cardiovascular disease, pharmaceutical preparations for the treatment of central nervous system diseases and disorders, namely CNS infections, brain diseases, depression, psychosis, schizophrenia and insomnia, pharmaceutical preparations for the treatment of neurological disorders, namely depression, psychosis, schizophrenia and insomnia; pharmaceutical preparations for the treatment of urological and urogenital disorders, namely bladder cancer; pharmaceutical preparations for the treatment of gastrointestinal disorders, namely digestive enzymes for use in pancreatic deficiency enzymes; anti-spasmodics; pharmaceutical preparations for anaesthesiology, namely muscle relaxants and muscle relaxant antagonists; pharmaceutical preparations for the treatment of allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity; pharmaceutical preparations for the treatment of respiratory and infectious diseases, namely influenza; pharmaceutical preparations for the treatment of immunological and viral disorders, namely rheumatoid arthritis and influenza; pharmaceutical preparations for the treatment of immunological and viral disorders, namely rheumatoid arthritis and influenza; pharmaceutical preparations for the treatment of mental illness, namely depression, psychosis, schizophrenia and insomnia; pharmaceutical preparations for the treatment of depression, psychosis, bone and mineral diseases, infertility, menopausal complaints, hormone deficiencies, and sleep disorders; pharmaceutical preparations, namely, smoking cessation preparations, tissue and skin repair preparations; dermatological preparations namely, skin disorders of an inflammatory and/or allergic nature; gynaecological preparations, namely hormonal contraceptives, hormone replacement therapies; intrauterine devices; contraceptives, muscle relaxants and muscle relaxant antagonists; contraceptives; contraceptive pharmaceutical preparations contained in or released from contraceptive sub-dermal implant; sub-dermal implant, namely non-degradable implant to be inserted under the skin, releasing hormones. | | 
